BSC
MRVI icon

BOLTON SECURITIES CORPORATION’s Maravai LifeSciences MRVI Stock Holding History

BOLTON SECURITIES CORPORATION’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-10,000
Closed -$62.4K – 2311
2026
Q2 		$62.4K Buy
+10,000
New +$43.2K ﹤0.01% 1257

Other funds holding MRVI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $63.7B AUM 20.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
General American Investors
General American Investors New York $1.71B AUM 30.1% 1-Year Est. Return
Royce & Associates
Royce & Associates New York $11B AUM 39.4% 1-Year Est. Return
Hillsdale Investment Management
Hillsdale Investment Management Toronto, Ontario, Canada $4.42B AUM 54.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $294B AUM 47.59% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

BOLTON SECURITIES CORPORATION's MRVI Position: Q3 2026 in Review

BOLTON SECURITIES CORPORATION sold out of Maravai LifeSciences (MRVI) in Q3 2026, closing a stake of 10,000 shares — an estimated $62.4K sold.

BOLTON SECURITIES CORPORATION first reported a position in MRVI in Q2 2026 and held it in 1 quarter. The position peaked at $62.4K in Q2 2026. 101 funds tracked by Wall St. Rank hold MRVI as of Q3 2026.

  • BOLTON SECURITIES CORPORATION reported no remaining Maravai LifeSciences position as of Q3 2026 after selling out during the quarter.
  • BOLTON SECURITIES CORPORATION sold 10,000 Maravai LifeSciences shares in Q3 2026, an estimated $62.4K.
  • BOLTON SECURITIES CORPORATION first reported a position in Maravai LifeSciences in Q2 2026 and held it in 1 quarter.
  • BOLTON SECURITIES CORPORATION's Maravai LifeSciences position peaked at $62.4K in Q2 2026.
  • 101 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q3 2026.

Based on BOLTON SECURITIES CORPORATION's 13F filing for Q3 2026, filed 12 Nov 2026.